ANXA2 and osteosarcoma: Additionally, it is demonstrated that S100A10 promotes the malignant growth of cancer cells by activating the AKT/mTOR signaling pathway in osteosarcoma [21] and the Src/ANXA2/AKT/mTOR signaling pathway in gastric cancer [19].